![logo](/logos/002004.SZ.webp)
Huapont Life Sciences Co., Ltd.
SZSE:002004.SZ
4.76 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 11,594.59 | 13,232.366 | 12,359.183 | 10,876.362 | 10,091.37 | 10,573.628 | 9,108.9 | 7,092.78 | 6,174.306 | 4,866.689 | 4,463.631 | 3,877.393 | 638.098 | 541.224 | 544.521 | 575.72 | 492.372 | 285.227 | 273.505 | 272.532 | 240.443 | 200.224 | 174.054 |
Cost of Revenue
| 7,059.524 | 7,874.068 | 7,605.558 | 6,421.314 | 5,395.796 | 6,281.663 | 6,195.071 | 4,752.611 | 4,040.404 | 3,383.451 | 3,297.061 | 2,892.849 | 211.723 | 176.882 | 189.709 | 203.165 | 182.627 | 63.661 | 63.197 | 64.569 | 70.742 | 63.985 | 56.41 |
Gross Profit
| 4,535.066 | 5,358.298 | 4,753.625 | 4,455.048 | 4,695.574 | 4,291.964 | 2,913.83 | 2,340.169 | 2,133.902 | 1,483.238 | 1,166.57 | 984.544 | 426.374 | 364.342 | 354.812 | 372.555 | 309.745 | 221.566 | 210.308 | 207.963 | 169.701 | 136.238 | 117.645 |
Gross Profit Ratio
| 0.391 | 0.405 | 0.385 | 0.41 | 0.465 | 0.406 | 0.32 | 0.33 | 0.346 | 0.305 | 0.261 | 0.254 | 0.668 | 0.673 | 0.652 | 0.647 | 0.629 | 0.777 | 0.769 | 0.763 | 0.706 | 0.68 | 0.676 |
Reseach & Development Expenses
| 419.139 | 385.239 | 329.471 | 324.353 | 288.027 | 349.462 | 210.624 | 140.404 | 131.323 | 98.85 | 73.623 | 61.913 | 12.344 | 10.939 | 0 | 0 | 4.28 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 432.553 | 540.625 | 400.552 | 403.093 | 398.25 | 362.682 | 268.079 | 227.665 | 183.758 | 139.534 | 109.61 | 98.521 | 40.353 | 39.053 | 85.334 | 86.962 | 21.669 | 45.995 | 48.961 | 40.412 | 31.079 | 19.291 | 15.93 |
Selling & Marketing Expenses
| 1,303.313 | 1,502.448 | 1,615.606 | 1,569.915 | 1,774.933 | 1,517.599 | 1,090.596 | 745.357 | 659.826 | 445.071 | 339.345 | 271.116 | 207.424 | 151.699 | 159.211 | 193.768 | 157.211 | 109.176 | 97.715 | 103.01 | 85.666 | 66.469 | 62.807 |
SG&A
| 1,735.866 | 2,043.072 | 2,016.157 | 1,973.008 | 2,173.183 | 1,880.281 | 1,358.676 | 973.021 | 843.584 | 584.605 | 448.955 | 369.636 | 247.777 | 190.751 | 244.545 | 280.73 | 178.88 | 155.171 | 146.676 | 143.422 | 116.745 | 85.76 | 78.737 |
Other Expenses
| -34.124 | 921.735 | 784.379 | 599.356 | 646.418 | 635.981 | 417.967 | 83.564 | -14.059 | 6.067 | 11.298 | 24.684 | 20.776 | 8.91 | 14.665 | 3.588 | 0.856 | 0.788 | 0.301 | 0.068 | 2.191 | -0.205 | -0.203 |
Operating Expenses
| 3,032.172 | 3,350.046 | 3,130.008 | 2,896.718 | 3,107.628 | 2,865.724 | 1,987.266 | 1,501.177 | 1,299.565 | 918.118 | 710.933 | 585.533 | 320.127 | 256.06 | 251.896 | 288.626 | 230.963 | 159.546 | 150.671 | 149.005 | 121.563 | 89.589 | 81.574 |
Operating Income
| 926.511 | 2,653.876 | 1,893.899 | 1,740.227 | 1,832.437 | 1,772.685 | 1,139.153 | 657.789 | 752.762 | 481.417 | 384.843 | 425.874 | 306.125 | 149.858 | 137.398 | 99.594 | 246.795 | 70.033 | 63.213 | 58.928 | 47.359 | 44.183 | 36.163 |
Operating Income Ratio
| 0.08 | 0.201 | 0.153 | 0.16 | 0.182 | 0.168 | 0.125 | 0.093 | 0.122 | 0.099 | 0.086 | 0.11 | 0.48 | 0.277 | 0.252 | 0.173 | 0.501 | 0.246 | 0.231 | 0.216 | 0.197 | 0.221 | 0.208 |
Total Other Income Expenses Net
| -34.124 | -1,031.18 | -607.896 | -575.144 | -683.09 | -698.582 | -457.381 | -138.683 | -77.024 | -68.099 | -64.965 | 47.051 | 219.595 | 43.267 | 44.472 | 18.875 | 167.284 | 6.548 | 2.484 | -0.377 | -3.159 | -2.953 | -0.113 |
Income Before Tax
| 892.388 | 1,622.696 | 1,286.003 | 1,165.083 | 1,149.347 | 1,074.103 | 681.772 | 700.309 | 757.313 | 497.02 | 390.672 | 446.063 | 325.842 | 151.549 | 147.388 | 102.805 | 246.067 | 69.694 | 62.817 | 58.789 | 47.265 | 43.837 | 35.959 |
Income Before Tax Ratio
| 0.077 | 0.123 | 0.104 | 0.107 | 0.114 | 0.102 | 0.075 | 0.099 | 0.123 | 0.102 | 0.088 | 0.115 | 0.511 | 0.28 | 0.271 | 0.179 | 0.5 | 0.244 | 0.23 | 0.216 | 0.197 | 0.219 | 0.207 |
Income Tax Expense
| 215.456 | 495.959 | 361.042 | 270.078 | 217.444 | 251.286 | 88.105 | 88.629 | 100.489 | 51.021 | 73.684 | 75.254 | 17.408 | 16.37 | 18.141 | 12.724 | 23.444 | 10.804 | 10.921 | 11.886 | 7.7 | 7.018 | 4.851 |
Net Income
| 302.122 | 1,126.736 | 924.961 | 895.006 | 931.903 | 822.817 | 507.906 | 566.868 | 636.625 | 429.184 | 302.449 | 332.384 | 305.279 | 132.042 | 127.684 | 88.81 | 206.455 | 58.446 | 52.499 | 47.648 | 39.922 | 37.295 | 31.108 |
Net Income Ratio
| 0.026 | 0.085 | 0.075 | 0.082 | 0.092 | 0.078 | 0.056 | 0.08 | 0.103 | 0.088 | 0.068 | 0.086 | 0.478 | 0.244 | 0.234 | 0.154 | 0.419 | 0.205 | 0.192 | 0.175 | 0.166 | 0.186 | 0.179 |
EPS
| 0.15 | 0.57 | 0.47 | 0.45 | 0.47 | 0.41 | 0.25 | 0.28 | 0.34 | 0.27 | 0.21 | 0.26 | 0.31 | 0.13 | 0.13 | 0.095 | 0.21 | 0.065 | 0.053 | 0.036 | 0.04 | 0.038 | 0.032 |
EPS Diluted
| 0.15 | 0.57 | 0.47 | 0.45 | 0.47 | 0.41 | 0.25 | 0.28 | 0.34 | 0.27 | 0.21 | 0.26 | 0.31 | 0.13 | 0.13 | 0.095 | 0.21 | 0.065 | 0.053 | 0.036 | 0.04 | 0.038 | 0.032 |
EBITDA
| 2,480.45 | 3,454.105 | 2,641.778 | 2,436.54 | 2,439.582 | 2,359.439 | 1,526.338 | 1,506.531 | 1,437.932 | 1,008.689 | 625.61 | 563.298 | 371.544 | 206.224 | 160.102 | 166.457 | 289.556 | 83.635 | 75.45 | 68.619 | 56.607 | 49.966 | 36.331 |
EBITDA Ratio
| 0.214 | 0.261 | 0.214 | 0.224 | 0.242 | 0.223 | 0.168 | 0.212 | 0.233 | 0.207 | 0.14 | 0.145 | 0.582 | 0.381 | 0.294 | 0.289 | 0.588 | 0.293 | 0.276 | 0.252 | 0.235 | 0.25 | 0.209 |